This profile is a brief introduction for people seeking employment in pharmaceutical graduate jobs, pharmaceutical nurse advisors, pharmaceutical sales jobs, pharmaceutical training jobs, pharmaceutical sales management jobs, pharmaceutical marketing jobs, pharmaceutical executive jobs, or pharmaceutical clinical research associates who may be considering working for AstraZeneca UK Limited.
Company Overview
Astra Zeneca, the UK's second biggest home grown "big pharma" company has continued to thrive over the last few years, despite some serious setbacks to its late - stage pipeline. Disappointments over first-in-class drug Exanta and Iressa have depleted the company's future prospects but worldwide sales rose 12% to $11.8 billion in the first half of 2005, with operating profit surging 44% in the same period.
UK sales have been hit in recent years, however, and in 2004 the company slid to fifth in overall sales from number three in 2000. UK sales have suffered since the patent expiry of Losec and a subsequent lack of enthusiasm for Nexium and statin Crestor, despite stronger update in other markets for these products. But strong growth in a number of other products, most notably anti- psychotic Seroquel and breast cancer drug Arimidex mean the company's future remains bright.
The company employs nearly 12,000 people in its R&D operations in England and Sweden. In the UK, Astra Zeneca employs around 10,200 in total with around 7,500 based in Cheshire, with UK headquarters and marketing offices based at Horizon Place near Luton. The company was ranked among the most respected pharma employers in a recent Science magazine survey.
The UK is one of the major hubs of AstraZeneca - one of the world's leading pharmaceutical companies
Our success is based on a commitment to discovery, finding new ideas that are inspired by life and which in turn help to inspire the lives of our stakeholders.
We discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. We also focus on getting the best from every medicine we make by exploring all the ways it can be used or improved.
At AstraZeneca, innovation is about more than just research. We aim to stimulate continued creativity throughout our organisation by maintaining a culture in which our people feel valued, energised and rewarded for their ideas and contribution to our success - ideas which can make a difference in all aspects of our business. And we support and encourage our people in discovering their own potential, through excellent learning and development opportunities that are available to them throughout their careers.
With a global business comes a global responsibility for consistently high standards of behaviour worldwide. We aim to effectively manage that responsibility and help to find new ways of bringing benefit to society to ensure that AstraZeneca continues to be welcomed as a valued member of the global community.
We are committed to continued achievement in all of these areas to ensure a healthy future for our business so that we can continue to help improve the lives of, and add value for, all those who benefit from it.
Product Overview
- Accolate - anti-inflammatory
- Amias - hypertension
- Arimidex - breast cancer
- Avloclor - malaria
- Bambec - asthma
- Betaloc - beta blocker
- Bricanyl - asthma
- Casodex - prostate cancer
- Citanest - local anaesthetic
- Crestor - statin
- Diprivan - general anaesthetic
- EMLA Cream - local anaesthetic
- Entocort - anti- inflammatory
- Faslodex - breast cancer
- Foscavir - to treat cytomegalovirus in patients with AIDS
- Heminevrin - severe insomnia, restlessness and agitated behaviour in
elderly people. Also used to treat the effects of acute alcohol withdrawal
- Imdur - angina
- Inderal LA - beta blocker
- Kalten - beta blocker
- Losec - PPI
- Marcain - local anaesthetic
- Meronem - anti- biotic
- Naropin - Local anaesthetic
- Nexium - PPI
- Nolvadex - breast cancer and infertility
- Oxis - asthma
- Paludrine - malaria
- Plendil - hypertension & angina
- Pulmicort - asthma
- Rhinocort - hayfever, allergies, sinusitis and nasal polyps
- Seroquel - schizophrenia and manic episodes associated with bipolar disorder
- Symbicort - asthma
- Tenif - hypertension & angina
- Tenoret 50 - hypertension
- Tenoretic - hypertension
- Tenormin - angina & hypertension
- Tomudex - colorectal cancer
- Xylocaine - local anaesthetic
- Xyloproct - haemorrhoids
- Zestoretic - hypertension
- Zestril - hypertension, heart failure, diabetes & post management
treatment after a heart attack - Zoladex 3.6mg/Men - prostate cancer
- Zoladex 3.6mg/Women - breast cancer
- Zomig - migraine
